Suppr超能文献

髋部骨折后的症状性静脉血栓栓塞症。

Symptomatic venous thromboembolism following a hip fracture.

机构信息

Department of Trauma and Orthopaedics, Peterborough Hospital, UK.

出版信息

Acta Orthop. 2009 Dec;80(6):687-92. doi: 10.3109/17453670903448273.

Abstract

BACKGROUND AND PURPOSE

Venous thromboembolism (VTE) remains a substantial cause of morbidity and mortality following hip fracture. Previous work has not identified any risk factors associated with the type of hip fracture. We report the incidence of and risk factors for development of symptomatic VTE in patients following a hip fracture.

PATIENTS AND METHODS

In this prospective study, we collected information on 5,300 consecutive patients who were admitted to a single unit with a hip fracture-in terms of their pre-admission status, details of any operation performed, and details of complications in the form of symptomatic venous thromboembolism. All patients received thromboprophylaxis with heparin.

RESULTS

The incidence of symptomatic VTE was 2.2% (95% CI: 1.8-2.6). 85% of these events occurred within 5 weeks of the fracture. The statistically significant risk factors for symptomatic VTE were better preoperative mobility, living in one's own home, high mental test score, high preoperative hemoglobin, inter-trochanteric fractures, and fixation with a dynamic hip screw. In multivariate analysis adjusting for sex and age, type of residence on admission, type of fracture, and hemoglobin values on admission remained independently significant.

INTERPRETATION

We found that the rate of symptomatic VTE using thromboprophylaxis with heparin was low but that there were a number of groups that were at a significantly higher risk of developing VTE. The patients who are particularly at risk appear to be those with a subtrochanteric or intertrochanteric hip fracture; here, the incidence of symptomatic VTE was twice that of intracapsular hip fractures.

摘要

背景与目的

静脉血栓栓塞症(VTE)仍然是髋部骨折后发病率和死亡率的重要原因。既往研究并未发现与髋部骨折类型相关的任何危险因素。我们报告髋部骨折患者发生有症状 VTE 的发生率和危险因素。

患者与方法

在这项前瞻性研究中,我们收集了 5300 例连续髋部骨折患者的信息,内容包括他们的入院前状态、任何手术的详细信息以及以有症状静脉血栓栓塞症形式出现的并发症的详细信息。所有患者均接受肝素预防性抗凝治疗。

结果

有症状 VTE 的发生率为 2.2%(95%CI:1.8-2.6)。其中 85%的事件发生在骨折后 5 周内。有症状 VTE 的统计学显著危险因素包括术前活动能力较好、居住在自己家中、精神测试评分较高、术前血红蛋白较高、转子间骨折以及采用动力髋螺钉固定。在调整性别和年龄、入院时的居住类型、骨折类型以及入院时的血红蛋白值的多变量分析中,这些因素仍然具有显著意义。

解释

我们发现,使用肝素预防性抗凝治疗的有症状 VTE 发生率较低,但有许多群体发生 VTE 的风险显著增加。特别有风险的患者似乎是那些存在转子下或转子间髋部骨折的患者;这里,有症状 VTE 的发生率是囊内髋部骨折的两倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8882/2823318/5a623cb4c3f0/ORT-1745-3674-80-687-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验